Cargando…
Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
BACKGROUND/AIMS: Portal vein invasion (PVI) is a poor prognostic factor in patients with hepatocellular carcinoma (HCC). We intended to compare the effects of surgical resection and transarterial chemoembolization (TACE) with additional radiation therapy (RT) in HCC patients with PVI. METHODS: The s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038940/ https://www.ncbi.nlm.nih.gov/pubmed/29665630 http://dx.doi.org/10.3350/cmh.2017.0041 |
_version_ | 1783338593303920640 |
---|---|
author | Lee, Danbi Lee, Han Chu An, Jihyun Shim, Ju Hyun Kim, Kang Mo Lim, Young-Suk Chung, Young-Hwa Lee, Yung Sang |
author_facet | Lee, Danbi Lee, Han Chu An, Jihyun Shim, Ju Hyun Kim, Kang Mo Lim, Young-Suk Chung, Young-Hwa Lee, Yung Sang |
author_sort | Lee, Danbi |
collection | PubMed |
description | BACKGROUND/AIMS: Portal vein invasion (PVI) is a poor prognostic factor in patients with hepatocellular carcinoma (HCC). We intended to compare the effects of surgical resection and transarterial chemoembolization (TACE) with additional radiation therapy (RT) in HCC patients with PVI. METHODS: The subjects comprised 43 patients who underwent surgical resection for HCC with PVI without previous treatment and another 43 patients who received TACE followed by RT (TACE+RT) as initial treatment who were matched for Child-Pugh class, tumor size, and extent of PVI. Disease progression and death after the treatment were examined, and progression-free survival (PFS) and overall survival (OS) were compared between groups. Predisposing factors affecting OS were analyzed using univariate and multivariate analyses in HCC patients with PVI. RESULTS: The subjects (Age [51, 24-74; median, range], Sex [81/13; male/female], Etiology [78/1/15; hepatitis B virus {HBV}/ hepatitis C virus {HCV}/non-HBV and non-HCV]) were followed for a median of 17 (2-68) months. There were no differences in clinical or tumor characteristics between the resection and TACE+RT groups. The cumulative PFS was not significantly different between groups. The median PFS was 5.6 and 4.0 months in the resection and TACE+RT groups, respectively. However, the cumulative OS was significantly longer in patients treated with resection than in those treated with TACE+RT (P=0.04). The median OS was 26.9 and 14.2 months in the resection and TACE+RT groups, respectively. Univariate and multivariate analyses revealed that surgical resection was an independent predictive factor for better survival outcome. CONCLUSIONS: Surgical resection might be an effective treatment in HCC patients with PVI. |
format | Online Article Text |
id | pubmed-6038940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-60389402018-07-18 Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion Lee, Danbi Lee, Han Chu An, Jihyun Shim, Ju Hyun Kim, Kang Mo Lim, Young-Suk Chung, Young-Hwa Lee, Yung Sang Clin Mol Hepatol Original Article BACKGROUND/AIMS: Portal vein invasion (PVI) is a poor prognostic factor in patients with hepatocellular carcinoma (HCC). We intended to compare the effects of surgical resection and transarterial chemoembolization (TACE) with additional radiation therapy (RT) in HCC patients with PVI. METHODS: The subjects comprised 43 patients who underwent surgical resection for HCC with PVI without previous treatment and another 43 patients who received TACE followed by RT (TACE+RT) as initial treatment who were matched for Child-Pugh class, tumor size, and extent of PVI. Disease progression and death after the treatment were examined, and progression-free survival (PFS) and overall survival (OS) were compared between groups. Predisposing factors affecting OS were analyzed using univariate and multivariate analyses in HCC patients with PVI. RESULTS: The subjects (Age [51, 24-74; median, range], Sex [81/13; male/female], Etiology [78/1/15; hepatitis B virus {HBV}/ hepatitis C virus {HCV}/non-HBV and non-HCV]) were followed for a median of 17 (2-68) months. There were no differences in clinical or tumor characteristics between the resection and TACE+RT groups. The cumulative PFS was not significantly different between groups. The median PFS was 5.6 and 4.0 months in the resection and TACE+RT groups, respectively. However, the cumulative OS was significantly longer in patients treated with resection than in those treated with TACE+RT (P=0.04). The median OS was 26.9 and 14.2 months in the resection and TACE+RT groups, respectively. Univariate and multivariate analyses revealed that surgical resection was an independent predictive factor for better survival outcome. CONCLUSIONS: Surgical resection might be an effective treatment in HCC patients with PVI. The Korean Association for the Study of the Liver 2018-06 2018-01-16 /pmc/articles/PMC6038940/ /pubmed/29665630 http://dx.doi.org/10.3350/cmh.2017.0041 Text en Copyright © 2018 by Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Lee, Danbi Lee, Han Chu An, Jihyun Shim, Ju Hyun Kim, Kang Mo Lim, Young-Suk Chung, Young-Hwa Lee, Yung Sang Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion |
title | Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion |
title_full | Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion |
title_fullStr | Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion |
title_full_unstemmed | Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion |
title_short | Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion |
title_sort | comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038940/ https://www.ncbi.nlm.nih.gov/pubmed/29665630 http://dx.doi.org/10.3350/cmh.2017.0041 |
work_keys_str_mv | AT leedanbi comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion AT leehanchu comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion AT anjihyun comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion AT shimjuhyun comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion AT kimkangmo comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion AT limyoungsuk comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion AT chungyounghwa comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion AT leeyungsang comparisonofsurgicalresectionversustransarterialchemoembolizationwithadditionalradiationtherapyinpatientswithhepatocellularcarcinomawithportalveininvasion |